MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watts, V. J.
Right arrow Articles by Neve, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watts, V. J.
Right arrow Articles by Neve, K. A.

Vol. 60, Issue 6, 1168-1172, December 2001

ACCELERATED COMMUNICATION
Dopamine D2 Receptor-Induced Heterologous Sensitization of Adenylyl Cyclase Requires Galpha s: Characterization of Galpha s-Insensitive Mutants of Adenylyl Cyclase V

Val J. Watts, Ronald Taussig, Rachael L. Neve, and Kim A. Neve

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana (V.J.W.); Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan (R.T.); Department of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, Massachusetts (R.L.N.); Department of Behavioral Neuroscience, Oregon Health Sciences University, Portland, Oregon (K.A.N); and Medical Research Service, Veterans Affairs Medical Center, Portland, Oregon (K.A.N.)

Whereas acute stimulation of Galpha i/o-coupled receptors inhibits the activity of adenylyl cyclase, a delayed consequence of persistent activation of the receptors is heterologous sensitization, an enhanced responsiveness of adenylyl cyclase to activators such as forskolin or agonists of Galpha s-coupled receptors. Galpha s-insensitive mutants of adenylyl cyclase type V were used to test the hypothesis that heterologous sensitization requires Galpha s-dependent activation of adenylyl cyclase. When adenylyl cyclase was stably expressed in human embryonic kidney (HEK) 293 cells with the D2L dopamine receptor, basal, forskolin-stimulated, and isoproterenol-stimulated cyclic AMP accumulation were all enhanced by 2-h pretreatment with the D2 receptor agonist quinpirole. Transient expression of wild-type adenylyl cyclase and three Galpha s-insensitive mutants (F379L, R1021Q, and F1093S) in HEK293 cells stably expressing the D2L receptor demonstrated that all three mutants had little or no responsiveness to beta -adrenergic receptor-mediated activation of Galpha s but that the mutants retained sensitivity to forskolin and to D2L receptor-mediated inhibition. Transiently expressed adenylyl cyclase V was robustly sensitized by 2-h pretreatment with quinpirole. In contrast, the Galpha s-insensitive mutants displayed no sensitization of forskolin-stimulated cyclic AMP accumulation, indicating that responsiveness to Galpha s is required for the expression of heterologous sensitization.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
T. A. Vortherms, C. H. Nguyen, C. H. Berlot, and V. J. Watts
Using Molecular Tools to Dissect the Role of G{alpha}s in Sensitization of AC1
Mol. Pharmacol., December 1, 2004; 66(6): 1617 - 1624.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. J. Clark, R. R. Neubig, and J. R. Traynor
Endogenous Regulator of G Protein Signaling Proteins Suppress G{alpha}o-Dependent, {micro}-Opioid Agonist-Mediated Adenylyl Cyclase Supersensitization
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 215 - 222.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. J. Millan, D. Cussac, A. Gobert, F. Lejeune, J.-M. Rivet, C. M. La Cour, A. Newman-Tancredi, and J.-L. Peglion
S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: I. Cellular, Electrophysiological, and Neurochemical Profile in Comparison with Ropinirole
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 903 - 920.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. A. Drakulich, A. M. Walls, M. L. Toews, and T. D. Hexum
Neuropeptide Y Receptor-Mediated Sensitization of ATP-Stimulated Inositol Phosphate Formation
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 559 - 565.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
V. J. Watts
Molecular Mechanisms for Heterologous Sensitization of Adenylate Cyclase
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 1 - 7.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. T. Auman, F. J. Seidler, C. A. Tate, and T. A. Slotkin
Are developing beta -adrenoceptors able to desensitize? Acute and chronic effects of beta -agonists in neonatal heart and liver
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R205 - R217.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
R. K. Sunahara and R. Taussig
Isoforms of Mammalian Adenylyl Cyclase: Multiplicities of Signaling
Mol. Interv., June 1, 2002; 2(3): 168 - 184.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics